NCT00805584View on ClinicalTrials.gov

Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)

PHASE4CompletedINTERVENTIONAL

Enrollment

311

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG

desloratadine

Aerius (desloratadine) tablets; 5mg orally once a day in the morning for 15 days

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00805584 - Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442) | Biotech Hunter | Biotech Hunter